We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
-8.73%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$308M
AUM Growth
-$44.2M
Cap. Flow
-$4.71M
Cap. Flow %
-1.53%
Top 10 Hldgs %
25.53%
Holding
393
New
63
Increased
64
Reduced
89
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.58M
2
CAG icon
Conagra Brands
CAG
+$6.41M
3
GIS icon
General Mills
GIS
+$6.28M
4
BDX icon
Becton Dickinson
BDX
+$6.25M
5
PG icon
Procter & Gamble
PG
+$6.16M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$8.69M
2
ZBRA icon
Zebra Technologies
ZBRA
+$8.06M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$7.68M
4
MCO icon
Moody's
MCO
+$7.1M
5
ZTS icon
Zoetis
ZTS
+$6.57M

Sector Composition

Rank Sector Weight
1 Healthcare 18.62%
2 Financials 14.7%
3 Energy 12.88%
4 Consumer Staples 11.59%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRP icon
251
TC Energy
TRP
$65.6B
$16K 0.01%
300
– –
BIT icon
252
BlackRock Multi-Sector Income Trust
BIT
$703M
$14K ﹤0.01%
1,000
– –
SCHA icon
253
Schwab U.S Small- Cap ETF
SCHA
$23B
$14K ﹤0.01%
708
+168
+31% +$3.59K
TDC icon
254
Teradata
TDC
$2.55B
$13K ﹤0.01%
354
– –
CAKE icon
255
Cheesecake Factory
CAKE
$5.38B
$11K ﹤0.01%
425
– –
HAS icon
256
Hasbro
HAS
$13.2B
$9K ﹤0.01%
115
-4,311
-97% -$373K
VYX icon
257
NCR Voyix
VYX
$1.12B
$9K ﹤0.01%
463
– –
CEG icon
258
Constellation Energy
CEG
$96.9B
$8K ﹤0.01%
+140
New +$8.42K
GE icon
259
GE Aerospace
GE
$383B
$8K ﹤0.01%
201
– –
VUG icon
260
Vanguard Morningstar Growth ETF
VUG
$230B
$8K ﹤0.01%
216
– –
NEE icon
261
NextEra Energy
NEE
$177B
$7K ﹤0.01%
88
-260
-75% -$19.8K
SCHF icon
262
Schwab International Equity ETF
SCHF
$68.4B
$7K ﹤0.01%
422
– –
USB icon
263
US Bancorp
USB
$100B
$7K ﹤0.01%
155
– –
CYTK icon
264
Cytokinetics
CYTK
$10.3B
$6K ﹤0.01%
143
– –
DELL icon
265
Dell
DELL
$302B
$6K ﹤0.01%
121
– –
HRMY icon
266
Harmony Biosciences
HRMY
$2.27B
$6K ﹤0.01%
+114
New +$5.13K
MTB icon
267
M&T Bank
MTB
$36.2B
$6K ﹤0.01%
+35
New +$5.88K
VMW
268
DELISTED
VMware, Inc
VMW
$6K ﹤0.01%
53
– –
ABM icon
269
ABM Industries
ABM
$2.82B
$5K ﹤0.01%
108
– –
AIN icon
270
Albany International
AIN
$1.75B
$5K ﹤0.01%
58
– –
AVA icon
271
Avista
AVA
$3.19B
$5K ﹤0.01%
109
– –
AWR icon
272
American States Water
AWR
$3.43B
$5K ﹤0.01%
59
– –
BDC icon
273
Belden
BDC
$5.24B
$5K ﹤0.01%
90
– –
CDP icon
274
COPT Defense Properties
CDP
$4.14B
$5K ﹤0.01%
176
– –
CORT icon
275
Corcept Therapeutics
CORT
$12.3B
$5K ﹤0.01%
216
– –
9 10
11
12 13

Similar funds

SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
BRIM
Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Contravisory Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Contravisory Investment Management held 393 positions worth $308M, down 13% from $352M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Contravisory Investment Management's Q2 2022 filing shows 63 new, 64 increased, 89 reduced and 70 closed positions. Its largest new stake was Conagra Brands: 188,092 shares worth $6.44M. The largest sale was Accenture, an estimated $8.69M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Energy.

  • Contravisory Investment Management's largest Q2 2022 buy was Conagra Brands: 188,092 shares worth $6.44M.
  • Contravisory Investment Management added most to Merck in Q2 2022, an estimated $6.58M increase.
  • Contravisory Investment Management's biggest Q2 2022 reduction was Accenture, cutting an estimated $8.69M.
  • Contravisory Investment Management fully exited Zebra Technologies in Q2 2022, selling an estimated $8.06M.
  • Contravisory Investment Management's ten largest holdings make up 26% of its $308M portfolio in Q2 2022.
  • Contravisory Investment Management opened 63 new positions and closed 70 in Q2 2022.
  • Contravisory Investment Management's portfolio value fell 13% quarter-over-quarter to $308M.

Based on Contravisory Investment Management's 13F filing for Q2 2022, filed 13 Jul 2022.